Publications

In silico transcriptome-based drug screening identifies celastrol as a multi-species therapeutic agent against aging-related sarcopenia and mitochondrial dysfunction

 9
In silico transcriptome-based drug screening identifies celastrol as a multi-species therapeutic agent against aging-related sarcopenia and mitochondrial dysfunction

Tags:

Previous Article

Zinc finger proteins act on gene promoters to control differentiation of stem cells

Next Article

Celastrol prevents aging-related sarcopenia and mitochondrial dysfunction

Related Posts

Imidazole propionate is a driver and therapeutic target in atherosclerosis

Imidazole propionate is a driver and therapeutic target...

 185

Structural basis of μ-opioid receptor targeting by a nanobody antagonist

Structural basis of μ-opioid receptor targeting by a na...

 101

Ergothioneine improves healthspan of aged animals by enhancing cGPDH activity through CSE- dependent persulfidation

Ergothioneine improves healthspan of aged animals by e...

 84